147 related articles for article (PubMed ID: 31138944)
1. Presentation and survival of multiple myeloma patients in Ghana: a review of 169 cases.
Acquah ME; Hsing AW; McGuire V; Wang S; Birmann B; Dei-Adomakoh Y
Ghana Med J; 2019 Mar; 53(1):52-58. PubMed ID: 31138944
[TBL] [Abstract][Full Text] [Related]
2. Factors affecting outcome of patients with multiple myeloma.
Basit A; Siddiqui N; Hameed A; Muzaffar N; Athar S
J Ayub Med Coll Abbottabad; 2014; 26(3):376-9. PubMed ID: 25671952
[TBL] [Abstract][Full Text] [Related]
3. [Clinical features and survival of Chilean patients with multiple myeloma].
Conté L G; Figueroa M G; Lois V V; Cabrera C ME; León R A; García L H; Rojas R H
Rev Med Chil; 2007 Sep; 135(9):1111-7. PubMed ID: 18064364
[TBL] [Abstract][Full Text] [Related]
4. MUSCULOSKELETAL PRESENTATION OF MULTIPLE MYELOMA AT GENERAL HOSPITAL DOUALA, CAMEROON.
Doualla-Bija M; Ndongho EN; Oben DT; Namme HL; Mbanya D
East Afr Med J; 2014 Sep; 91(9):311-6. PubMed ID: 26866083
[TBL] [Abstract][Full Text] [Related]
5. Hypercalcemia remains an adverse prognostic factor for newly diagnosed multiple myeloma patients in the era of novel antimyeloma therapies.
Zagouri F; Kastritis E; Zomas A; Terpos E; Katodritou E; Symeonidis A; Delimpasi S; Pouli A; Vassilakopoulos TP; Michalis E; Giannouli S; Kartasis Z; Christoforidou A; Kokoviadou K; Hatzimichael E; Gika D; Megalakaki C; Papaioannou M; Kyrtsonis MC; Konstantopoulos K; Dimopoulos MA;
Eur J Haematol; 2017 Nov; 99(5):409-414. PubMed ID: 28675766
[TBL] [Abstract][Full Text] [Related]
6. Hypercalcemia caused by humoral effects and bone damage indicate poor outcomes in newly diagnosed multiple myeloma patients.
Bao L; Wang Y; Lu M; Chu B; Shi L; Gao S; Fang L; Xiang Q
Cancer Med; 2020 Dec; 9(23):8962-8969. PubMed ID: 33145966
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic value of the new international staging system in multiple myeloma. Comparison with Durie-Salmon staging system].
Conté L G; Figueroa M G; Lois V V; Cabrera C ME; León R A; García L H; Rojas R H
Rev Med Chil; 2008 Jan; 136(1):7-12. PubMed ID: 18483648
[TBL] [Abstract][Full Text] [Related]
8. Multiple myeloma with unexplained isolated anaemia in a 24year old man- a case report.
Aworanti OW; Ogundeji SP; Adeoye OA; Shokunbi WA
Afr Health Sci; 2022 Dec; 22(4):64-69. PubMed ID: 37092066
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological features and management of Pakistani patients with multiple myeloma.
Shaheen H; Ghanghroo I; Malik I
J Pak Med Assoc; 1999 Oct; 49(10):233-7. PubMed ID: 10647226
[TBL] [Abstract][Full Text] [Related]
10. Review of 1027 patients with newly diagnosed multiple myeloma.
Kyle RA; Gertz MA; Witzig TE; Lust JA; Lacy MQ; Dispenzieri A; Fonseca R; Rajkumar SV; Offord JR; Larson DR; Plevak ME; Therneau TM; Greipp PR
Mayo Clin Proc; 2003 Jan; 78(1):21-33. PubMed ID: 12528874
[TBL] [Abstract][Full Text] [Related]
11. Presenting Signs of Multiple Myeloma and the Effect of Diagnostic Delay on the Prognosis.
Goldschmidt N; Zamir L; Poperno A; Kahan NR; Paltiel O
J Am Board Fam Med; 2016 Nov; 29(6):702-709. PubMed ID: 28076253
[TBL] [Abstract][Full Text] [Related]
12. [Long-term survival and prognostic factors in stage II-III multiple myeloma treated with conventional chemotherapy].
Pertuiset E; Chevret S; Lioté F; Delauche MC; Bardin T; Dryll A; Kuntz D
Ann Med Interne (Paris); 1992; 143(8):519-24. PubMed ID: 1303595
[TBL] [Abstract][Full Text] [Related]
13. International staging system for multiple myeloma.
Greipp PR; San Miguel J; Durie BG; Crowley JJ; Barlogie B; Bladé J; Boccadoro M; Child JA; Avet-Loiseau H; Kyle RA; Lahuerta JJ; Ludwig H; Morgan G; Powles R; Shimizu K; Shustik C; Sonneveld P; Tosi P; Turesson I; Westin J
J Clin Oncol; 2005 May; 23(15):3412-20. PubMed ID: 15809451
[TBL] [Abstract][Full Text] [Related]
14. Macrofocal multiple myeloma in young patients: a distinct entity with favorable prognosis.
Dimopoulos MA; Pouli A; Anagnostopoulos A; Repoussis P; Symeonidis A; Terpos E; Delimbasi S; Tsolakis F; Economopoulos T; Zervas C
Leuk Lymphoma; 2006 Aug; 47(8):1553-6. PubMed ID: 16966266
[TBL] [Abstract][Full Text] [Related]
15. [Role of radiotherapy in the treatment of multiple myeloma].
Mose S; Pfitzner D; Rahn A; Nierhoff C; Schiemann M; Böttcher HD
Strahlenther Onkol; 2000 Nov; 176(11):506-12. PubMed ID: 11143524
[TBL] [Abstract][Full Text] [Related]
16. Multiple myeloma in elderly patients: prognostic factors and outcome.
Anagnostopoulos A; Gika D; Symeonidis A; Zervas K; Pouli A; Repoussis P; Grigoraki V; Anagnostopoulos N; Economopoulos T; Maniatis A; Dimopoulos MA
Eur J Haematol; 2005 Nov; 75(5):370-5. PubMed ID: 16191085
[TBL] [Abstract][Full Text] [Related]
17. The Effect of Suppressed Levels of Uninvolved Immunoglobulins on the Prognosis of Symptomatic Multiple Myeloma.
Sarı M; Sarı S; Nalçacı M
Turk J Haematol; 2017 Jun; 34(2):131-136. PubMed ID: 27795224
[TBL] [Abstract][Full Text] [Related]
18. Presentation and survival of patients with severe renal failure and myeloma.
Irish AB; Winearls CG; Littlewood T
QJM; 1997 Dec; 90(12):773-80. PubMed ID: 9536342
[TBL] [Abstract][Full Text] [Related]
19. Erythropoiesis-stimulating agents are associated with reduced survival in patients with multiple myeloma.
Katodritou E; Verrou E; Hadjiaggelidou C; Gastari V; Laschos K; Kontovinis L; Kapetanos D; Constantinou N; Terpos E; Zervas K
Am J Hematol; 2008 Sep; 83(9):697-701. PubMed ID: 18626886
[TBL] [Abstract][Full Text] [Related]
20. Renal impairment in patients with multiple myeloma.
Chow CC; Mo KL; Chan CK; Lo HK; Wong KS; Chan JC
Hong Kong Med J; 2003 Apr; 9(2):78-82. PubMed ID: 12668816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
